[Diagnostic and therapeutic management in malignant neck tumors of unknown origin. Our experience in the last 5 years].
The AA. analyzed 37 cases of metastatic neck cancer from unknown primary sites treated at the Oncologic Unit from 1986 to October 1991. This group account for 7 percent of total cervicofacial tumors seen. Factors that affected survival include the symptoms of consult, the control of cervical disease after treatment and surgery. The survival was 50 percent at two years and the rate of neck disease control amounted to 57.7 percent.
Pardal Refoyo
J L
JL
Servicio de Otorrinolaringologia, Hospital Clinico Universitario, Salamanca.
Muñoz Herrera
A
A
Gómez González
J L
JL
Flores Corral
T
T
García García
A I
AI
D000230:Adenocarcinoma / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D002277:Carcinoma / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D006801:Humans; D008297:Male; D008545:Melanoma / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D008875:Middle Aged; D011379:Prognosis
Manejo diagnóstico y terapéutico en tumores malignos cervicales de origen desconocido. Nuestra experiencia en los últimos cinco años.